T46.- Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system

Excludes

  • Poisoning by, adverse effect of and underdosing of metaraminol (T44.4)
  • T46
  • Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system
    • T46.0
    Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
      • T46.0X
    Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
          • T46.0X1
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional)
                  • T46.0X1A
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
                  • T46.0X1D
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter
                  • T46.0X1S
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela
          • T46.0X2
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm
                  • T46.0X2A
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
                  • T46.0X2D
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter
                  • T46.0X2S
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
          • T46.0X3
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault
                  • T46.0X3A
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
                  • T46.0X3D
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
                  • T46.0X3S
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela
          • T46.0X4
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined
                  • T46.0X4A
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
                  • T46.0X4D
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
                  • T46.0X4S
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela
          • T46.0X5
    Adverse effect of cardiac-stimulant glycosides and drugs of similar action
                  • T46.0X5A
    Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
                  • T46.0X5D
    Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
                  • T46.0X5S
    Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
          • T46.0X6
    Underdosing of cardiac-stimulant glycosides and drugs of similar action
                  • T46.0X6A
    Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
                  • T46.0X6D
    Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
                  • T46.0X6S
    Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
    • T46.1
    Poisoning by, adverse effect of and underdosing of calcium-channel blockers
      • T46.1X
    Poisoning by, adverse effect of and underdosing of calcium-channel blockers
          • T46.1X1
    Poisoning by calcium-channel blockers, accidental (unintentional)
                  • T46.1X1A
    Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter
                  • T46.1X1D
    Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter
                  • T46.1X1S
    Poisoning by calcium-channel blockers, accidental (unintentional), sequela
          • T46.1X2
    Poisoning by calcium-channel blockers, intentional self-harm
                  • T46.1X2A
    Poisoning by calcium-channel blockers, intentional self-harm, initial encounter
                  • T46.1X2D
    Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter
                  • T46.1X2S
    Poisoning by calcium-channel blockers, intentional self-harm, sequela
          • T46.1X3
    Poisoning by calcium-channel blockers, assault
                  • T46.1X3A
    Poisoning by calcium-channel blockers, assault, initial encounter
                  • T46.1X3D
    Poisoning by calcium-channel blockers, assault, subsequent encounter
                  • T46.1X3S
    Poisoning by calcium-channel blockers, assault, sequela
          • T46.1X4
    Poisoning by calcium-channel blockers, undetermined
                  • T46.1X4A
    Poisoning by calcium-channel blockers, undetermined, initial encounter
                  • T46.1X4D
    Poisoning by calcium-channel blockers, undetermined, subsequent encounter
                  • T46.1X4S
    Poisoning by calcium-channel blockers, undetermined, sequela
          • T46.1X5
    Adverse effect of calcium-channel blockers
                  • T46.1X5A
    Adverse effect of calcium-channel blockers, initial encounter
                  • T46.1X5D
    Adverse effect of calcium-channel blockers, subsequent encounter
                  • T46.1X5S
    Adverse effect of calcium-channel blockers, sequela
          • T46.1X6
    Underdosing of calcium-channel blockers
                  • T46.1X6A
    Underdosing of calcium-channel blockers, initial encounter
                  • T46.1X6D
    Underdosing of calcium-channel blockers, subsequent encounter
                  • T46.1X6S
    Underdosing of calcium-channel blockers, sequela
    • T46.2
    Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs, not elsewhere classified
      • T46.2X
    Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs
          • T46.2X1
    Poisoning by other antidysrhythmic drugs, accidental (unintentional)
                  • T46.2X1A
    Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
                  • T46.2X1D
    Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter
                  • T46.2X1S
    Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela
          • T46.2X2
    Poisoning by other antidysrhythmic drugs, intentional self-harm
                  • T46.2X2A
    Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
                  • T46.2X2D
    Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter
                  • T46.2X2S
    Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela
          • T46.2X3
    Poisoning by other antidysrhythmic drugs, assault
                  • T46.2X3A
    Poisoning by other antidysrhythmic drugs, assault, initial encounter
                  • T46.2X3D
    Poisoning by other antidysrhythmic drugs, assault, subsequent encounter
                  • T46.2X3S
    Poisoning by other antidysrhythmic drugs, assault, sequela
          • T46.2X4
    Poisoning by other antidysrhythmic drugs, undetermined
                  • T46.2X4A
    Poisoning by other antidysrhythmic drugs, undetermined, initial encounter
                  • T46.2X4D
    Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter
                  • T46.2X4S
    Poisoning by other antidysrhythmic drugs, undetermined, sequela
          • T46.2X5
    Adverse effect of other antidysrhythmic drugs
                  • T46.2X5A
    Adverse effect of other antidysrhythmic drugs, initial encounter
                  • T46.2X5D
    Adverse effect of other antidysrhythmic drugs, subsequent encounter
                  • T46.2X5S
    Adverse effect of other antidysrhythmic drugs, sequela
          • T46.2X6
    Underdosing of other antidysrhythmic drugs
                  • T46.2X6A
    Underdosing of other antidysrhythmic drugs, initial encounter
                  • T46.2X6D
    Underdosing of other antidysrhythmic drugs, subsequent encounter
                  • T46.2X6S
    Underdosing of other antidysrhythmic drugs, sequela
    • T46.3
    Poisoning by, adverse effect of and underdosing of coronary vasodilators
      • T46.3X
    Poisoning by, adverse effect of and underdosing of coronary vasodilators
          • T46.3X1
    Poisoning by coronary vasodilators, accidental (unintentional)
                  • T46.3X1A
    Poisoning by coronary vasodilators, accidental (unintentional), initial encounter
                  • T46.3X1D
    Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter
                  • T46.3X1S
    Poisoning by coronary vasodilators, accidental (unintentional), sequela
          • T46.3X2
    Poisoning by coronary vasodilators, intentional self-harm
                  • T46.3X2A
    Poisoning by coronary vasodilators, intentional self-harm, initial encounter
                  • T46.3X2D
    Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter
                  • T46.3X2S
    Poisoning by coronary vasodilators, intentional self-harm, sequela
          • T46.3X3
    Poisoning by coronary vasodilators, assault
                  • T46.3X3A
    Poisoning by coronary vasodilators, assault, initial encounter
                  • T46.3X3D
    Poisoning by coronary vasodilators, assault, subsequent encounter
                  • T46.3X3S
    Poisoning by coronary vasodilators, assault, sequela
          • T46.3X4
    Poisoning by coronary vasodilators, undetermined
                  • T46.3X4A
    Poisoning by coronary vasodilators, undetermined, initial encounter
                  • T46.3X4D
    Poisoning by coronary vasodilators, undetermined, subsequent encounter
                  • T46.3X4S
    Poisoning by coronary vasodilators, undetermined, sequela
          • T46.3X5
    Adverse effect of coronary vasodilators
                  • T46.3X5A
    Adverse effect of coronary vasodilators, initial encounter
                  • T46.3X5D
    Adverse effect of coronary vasodilators, subsequent encounter
                  • T46.3X5S
    Adverse effect of coronary vasodilators, sequela
          • T46.3X6
    Underdosing of coronary vasodilators
                  • T46.3X6A
    Underdosing of coronary vasodilators, initial encounter
                  • T46.3X6D
    Underdosing of coronary vasodilators, subsequent encounter
                  • T46.3X6S
    Underdosing of coronary vasodilators, sequela
    • T46.4
    Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
      • T46.4X
    Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
          • T46.4X1
    Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional)
                  • T46.4X1A
    Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
                  • T46.4X1D
    Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter
                  • T46.4X1S
    Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela
          • T46.4X2
    Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm
                  • T46.4X2A
    Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
                  • T46.4X2D
    Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter
                  • T46.4X2S
    Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela
          • T46.4X3
    Poisoning by angiotensin-converting-enzyme inhibitors, assault
                  • T46.4X3A
    Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
                  • T46.4X3D
    Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter
                  • T46.4X3S
    Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela
          • T46.4X4
    Poisoning by angiotensin-converting-enzyme inhibitors, undetermined
                  • T46.4X4A
    Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter
                  • T46.4X4D
    Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter
                  • T46.4X4S
    Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela
          • T46.4X5
    Adverse effect of angiotensin-converting-enzyme inhibitors
                  • T46.4X5A
    Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
                  • T46.4X5D
    Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
                  • T46.4X5S
    Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
          • T46.4X6
    Underdosing of angiotensin-converting-enzyme inhibitors
                  • T46.4X6A
    Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter
                  • T46.4X6D
    Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter
                  • T46.4X6S
    Underdosing of angiotensin-converting-enzyme inhibitors, sequela
    • T46.5
    Poisoning by, adverse effect of and underdosing of other antihypertensive drugs
      • T46.5X
    Poisoning by, adverse effect of and underdosing of other antihypertensive drugs
          • T46.5X1
    Poisoning by other antihypertensive drugs, accidental (unintentional)
                  • T46.5X1A
    Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
                  • T46.5X1D
    Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter
                  • T46.5X1S
    Poisoning by other antihypertensive drugs, accidental (unintentional), sequela
          • T46.5X2
    Poisoning by other antihypertensive drugs, intentional self-harm
                  • T46.5X2A
    Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter
                  • T46.5X2D
    Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter
                  • T46.5X2S
    Poisoning by other antihypertensive drugs, intentional self-harm, sequela
          • T46.5X3
    Poisoning by other antihypertensive drugs, assault
                  • T46.5X3A
    Poisoning by other antihypertensive drugs, assault, initial encounter
                  • T46.5X3D
    Poisoning by other antihypertensive drugs, assault, subsequent encounter
                  • T46.5X3S
    Poisoning by other antihypertensive drugs, assault, sequela
          • T46.5X4
    Poisoning by other antihypertensive drugs, undetermined
                  • T46.5X4A
    Poisoning by other antihypertensive drugs, undetermined, initial encounter
                  • T46.5X4D
    Poisoning by other antihypertensive drugs, undetermined, subsequent encounter
                  • T46.5X4S
    Poisoning by other antihypertensive drugs, undetermined, sequela
          • T46.5X5
    Adverse effect of other antihypertensive drugs
                  • T46.5X5A
    Adverse effect of other antihypertensive drugs, initial encounter
                  • T46.5X5D
    Adverse effect of other antihypertensive drugs, subsequent encounter
                  • T46.5X5S
    Adverse effect of other antihypertensive drugs, sequela
          • T46.5X6
    Underdosing of other antihypertensive drugs
                  • T46.5X6A
    Underdosing of other antihypertensive drugs, initial encounter
                  • T46.5X6D
    Underdosing of other antihypertensive drugs, subsequent encounter
                  • T46.5X6S
    Underdosing of other antihypertensive drugs, sequela
    • T46.6
    Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
      • T46.6X
    Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
          • T46.6X1
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional)
                  • T46.6X1A
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
                  • T46.6X1D
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter
                  • T46.6X1S
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela
          • T46.6X2
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm
                  • T46.6X2A
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter
                  • T46.6X2D
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter
                  • T46.6X2S
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela
          • T46.6X3
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault
                  • T46.6X3A
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter
                  • T46.6X3D
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter
                  • T46.6X3S
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela
          • T46.6X4
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined
                  • T46.6X4A
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter
                  • T46.6X4D
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter
                  • T46.6X4S
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela
          • T46.6X5
    Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs
                  • T46.6X5A
    Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
                  • T46.6X5D
    Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
                  • T46.6X5S
    Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
          • T46.6X6
    Underdosing of antihyperlipidemic and antiarteriosclerotic drugs
                  • T46.6X6A
    Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
                  • T46.6X6D
    Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
                  • T46.6X6S
    Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela
    • T46.7
    Poisoning by, adverse effect of and underdosing of peripheral vasodilators
      • T46.7X
    Poisoning by, adverse effect of and underdosing of peripheral vasodilators
          • T46.7X1
    Poisoning by peripheral vasodilators, accidental (unintentional)
                  • T46.7X1A
    Poisoning by peripheral vasodilators, accidental (unintentional), initial encounter
                  • T46.7X1D
    Poisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter
                  • T46.7X1S
    Poisoning by peripheral vasodilators, accidental (unintentional), sequela
          • T46.7X2
    Poisoning by peripheral vasodilators, intentional self-harm
                  • T46.7X2A
    Poisoning by peripheral vasodilators, intentional self-harm, initial encounter
                  • T46.7X2D
    Poisoning by peripheral vasodilators, intentional self-harm, subsequent encounter
                  • T46.7X2S
    Poisoning by peripheral vasodilators, intentional self-harm, sequela
          • T46.7X3
    Poisoning by peripheral vasodilators, assault
                  • T46.7X3A
    Poisoning by peripheral vasodilators, assault, initial encounter
                  • T46.7X3D
    Poisoning by peripheral vasodilators, assault, subsequent encounter
                  • T46.7X3S
    Poisoning by peripheral vasodilators, assault, sequela
          • T46.7X4
    Poisoning by peripheral vasodilators, undetermined
                  • T46.7X4A
    Poisoning by peripheral vasodilators, undetermined, initial encounter
                  • T46.7X4D
    Poisoning by peripheral vasodilators, undetermined, subsequent encounter
                  • T46.7X4S
    Poisoning by peripheral vasodilators, undetermined, sequela
          • T46.7X5
    Adverse effect of peripheral vasodilators
                  • T46.7X5A
    Adverse effect of peripheral vasodilators, initial encounter
                  • T46.7X5D
    Adverse effect of peripheral vasodilators, subsequent encounter
                  • T46.7X5S
    Adverse effect of peripheral vasodilators, sequela
          • T46.7X6
    Underdosing of peripheral vasodilators
                  • T46.7X6A
    Underdosing of peripheral vasodilators, initial encounter
                  • T46.7X6D
    Underdosing of peripheral vasodilators, subsequent encounter
                  • T46.7X6S
    Underdosing of peripheral vasodilators, sequela
    • T46.8
    Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
      • T46.8X
    Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
          • T46.8X1
    Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional)
                  • T46.8X1A
    Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
                  • T46.8X1D
    Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter
                  • T46.8X1S
    Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela
          • T46.8X2
    Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm
                  • T46.8X2A
    Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
                  • T46.8X2D
    Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter
                  • T46.8X2S
    Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela
          • T46.8X3
    Poisoning by antivaricose drugs, including sclerosing agents, assault
                  • T46.8X3A
    Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
                  • T46.8X3D
    Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter
                  • T46.8X3S
    Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela
          • T46.8X4
    Poisoning by antivaricose drugs, including sclerosing agents, undetermined
                  • T46.8X4A
    Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
                  • T46.8X4D
    Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter
                  • T46.8X4S
    Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
          • T46.8X5
    Adverse effect of antivaricose drugs, including sclerosing agents
                  • T46.8X5A
    Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
                  • T46.8X5D
    Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
                  • T46.8X5S
    Adverse effect of antivaricose drugs, including sclerosing agents, sequela
          • T46.8X6
    Underdosing of antivaricose drugs, including sclerosing agents
                  • T46.8X6A
    Underdosing of antivaricose drugs, including sclerosing agents, initial encounter
                  • T46.8X6D
    Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
                  • T46.8X6S
    Underdosing of antivaricose drugs, including sclerosing agents, sequela
    • T46.9
    Poisoning by, adverse effect of and underdosing of other and unspecified agents primarily affecting the cardiovascular system
      • T46.90
    Poisoning by, adverse effect of and underdosing of unspecified agents primarily affecting the cardiovascular system
          • T46.901
    Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional)
                  • T46.901A
    Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
                  • T46.901D
    Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
                  • T46.901S
    Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
          • T46.902
    Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm
                  • T46.902A
    Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
                  • T46.902D
    Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
                  • T46.902S
    Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela
          • T46.903
    Poisoning by unspecified agents primarily affecting the cardiovascular system, assault
                  • T46.903A
    Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
                  • T46.903D
    Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter
                  • T46.903S
    Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela
          • T46.904
    Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined
                  • T46.904A
    Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
                  • T46.904D
    Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
                  • T46.904S
    Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela
          • T46.905
    Adverse effect of unspecified agents primarily affecting the cardiovascular system
                  • T46.905A
    Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
                  • T46.905D
    Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
                  • T46.905S
    Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
          • T46.906
    Underdosing of unspecified agents primarily affecting the cardiovascular system
                  • T46.906A
    Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter
                  • T46.906D
    Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
                  • T46.906S
    Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela
      • T46.99
    Poisoning by, adverse effect of and underdosing of other agents primarily affecting the cardiovascular system
          • T46.991
    Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional)
                  • T46.991A
    Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
                  • T46.991D
    Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
                  • T46.991S
    Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
          • T46.992
    Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm
                  • T46.992A
    Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
                  • T46.992D
    Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
                  • T46.992S
    Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela
          • T46.993
    Poisoning by other agents primarily affecting the cardiovascular system, assault
                  • T46.993A
    Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
                  • T46.993D
    Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter
                  • T46.993S
    Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela
          • T46.994
    Poisoning by other agents primarily affecting the cardiovascular system, undetermined
                  • T46.994A
    Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
                  • T46.994D
    Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
                  • T46.994S
    Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela
          • T46.995
    Adverse effect of other agents primarily affecting the cardiovascular system
                  • T46.995A
    Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
                  • T46.995D
    Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
                  • T46.995S
    Adverse effect of other agents primarily affecting the cardiovascular system, sequela
          • T46.996
    Underdosing of other agents primarily affecting the cardiovascular system
                  • T46.996A
    Underdosing of other agents primarily affecting the cardiovascular system, initial encounter
                  • T46.996D
    Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
                  • T46.996S
    Underdosing of other agents primarily affecting the cardiovascular system, sequela